OTC naloxone is a baby step toward making the life-saving medication accessible Critiquing profiteering by naloxone manufacturers and proposing solutions to fix this issue.
Jonathan JK Stoltman, PhD
As states start to get opioid settlement cash, few are sharing how they spend it Promoting transparency with opioid settlement money to ensure it goes towards evidence-based solutions.
FDA approves overdose-reversing Narcan for over-the-counter sale Comments on how OTC naloxone isn’t enough to address issues with access.
Telehealth Sites Put Addiction Patient Data at Risk Our Report 2 covering privacy issues with mHealth addiction websites served as the foundation for this reporting.
Websites for Opioid Addiction Treatment and Recovery Services: Data Sharing and Privacy Risks Jonathan Stoltman, PhD (Opioid Policy Institute) Jacqueline Seitz, JD (Legal Action Center) Download Report Interactive Report (w/ data) Legal Action Center Support Our Work
About the Opioid Policy Institute We talk with Shelley Irwin about Reporting on Addiction and addiction science. 🔊10min listen
The Federal Website That’s Supposed to Help ‘Find Treatment’ Needs Work, Experts Say Provided thoughts on findtreatment.gov and how to improve this vital national resource.